Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows provided by operating activities:
Net (loss) income	$ (90)	$ 1,547
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization	181	164
Amortization of operating lease right-of-use assets	374	251
Stock based compensation	167	182
Change in deferred tax assets	34	(482)
Realized loss on sale of investment in iBio Stock	35	0
Unrealized (gain) loss on investment in iBio Stock	(27)	42
Other, Net	6	(6)
Changes in operating assets and liabilities:
Accounts receivable, net	379	309
Inventories	791	(1,426)
Other current assets	(187)	(313)
Security deposits and other assets	(21)	(9)
Accounts payable	(232)	835
Accrued expenses and other liabilities	(89)	(129)
Operating lease obligations	(373)	(252)
Net cash provided by operating activities	948	713
Cash flows from investing activities:
Purchase of property and equipment	(82)	(308)
Proceeds from sale of iBio Stock	4	0
Proceeds from sale of machinery and equipment	0	21
Net cash used in investing activities	(78)	(287)
Cash flows from financing activities:
Advances (repayments) under revolving credit facility	(101)	972
Proceeds from exercise of employee stock options	0	7
Repayments under term note payables	0	(1,453)
Repayments under finance lease obligations	(15)	0
Net cash used in financing activities	(116)	(474)
Net increase (decrease) in cash	754	(48)
Cash at beginning of period	331	210
Cash at end of period	1,085	162
Interest paid	21	59
Income taxes paid	0	371
Amount owed on purchase of property and equipment	$ 0	$ 2